ANN E. BERMAN - 15 Mar 2022 Form 4 Insider Report for Immuneering Corp (IMRX)

Role
Director
Signature
/s/ Michael D. Bookman, Attorney-in-Fact for Ann E. Berman
Issuer symbol
IMRX
Transactions as of
15 Mar 2022
Net transactions value
+$38,400
Form type
4
Filing time
15 Mar 2022, 17:53:34 UTC
Previous filing
02 Mar 2022
Next filing
11 May 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IMRX Class A Common Stock Purchase $38,400 +6,000 +171% $6.40 9,500 15 Mar 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This transaction was executed in multiple trades through a broker-dealer at prices ranging from $6.35 to $6.45. The price reported in this column reflects the weighted average purchase price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares acquired at each price.